Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1 EUR | 0.00% |
|
+6.95% | -9.09% |
30/04 | PT Gudang Garam Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
28/03 | PT Gudang Garam Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Strengths
- Its low valuation, with P/E ratio at 6.95 and 6.46 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The stock, which is currently worth 2024 to 306.87 times its sales, is clearly overvalued in comparison with peers.
- The company appears to be poorly valued given its net asset value.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.09% | 2.14B | - | ||
+14.85% | 79.73B | B- | ||
-8.26% | 63.34B | B | ||
+23.51% | 49.91B | A- | ||
-0.46% | 6.96B | A- | ||
-22.35% | 4.97B | A- | ||
-5.50% | 2.34B | C- | ||
-37.40% | 1.47B | - | ||
-19.01% | 1.14B | B | ||
-15.92% | 1.1B | D+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- GGRM Stock
- GGG Stock
- Ratings PT Gudang Garam Tbk